Antimicrobial activity of Buchenavia tetraphylla against Candida albicans strains isolated from vaginal secretions

References

• Agra MF, Baracho GS, Silva KN, Basílio IJLD, Coelho VPM. 2007. Medicinal and poisonous diversity of the flora of Cariri Paraibano, Brazil. J Ethnopharmacol. 111:383–395.
   PubMed Web of Science ®Google Scholar
• Agra MF, Silva KN, Basílio IJLD Freitas PF, Barbosa-Filho JM. 2008. Survey of medicinal plants used in the region northeast of Brazil. Braz J Pharmacog. 18:472–508.
   Web of Science ®Google Scholar
• Avijgan M, Mahboubi M, Nasab MM, Nia EA, Yousefi H. 2014. Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis. J Mycol Med. 24:112–116.
   PubMed Web of Science ®Google Scholar
• Berman J, Sudbery PE. 2002. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet. 3:918–932.
   PubMed Web of Science ®Google Scholar
• Blanco MT, Sacristán B, Lucio L, Blanco J, Pérez-Giraldo C, Gómez-García AC. 2009. Cell surface hydrophobicity as an indicator of other virulence factors in Candida albicans. Rev Iberoam Micol. 27:195–199.
   Web of Science ®Google Scholar
• Cassone A. 2014. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG. 122:785–794.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). 2011. Performance standards for antimicrobial susceptibility testing (21st edn) Wayne: M100-S21. Clin Lab Std Inst. 30.
   Google Scholar
• Collette JR, Zhou H, Lorenz MC. 2014. Candida albicans suppresses nitric oxide generation from macrophages via a secreted molecule. PLoS One. 9:e96203.
   PubMed Web of Science ®Google Scholar
• Cui J, Ren B, Tong Y, Dai H, Zhang L. 2015. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Virulence. 6:362–371.
   PubMed Web of Science ®Google Scholar
• da Silva CR, de Andrade Neto JB, de Sousa Campos R, Figueiredo NS, Sampaio LS, Magalhães HI, Cavalcanti BC, Gaspar DM, de Andrade GM, Lima IS, et al. 2014. Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole. Antimicrob Agents Chemother. 58:1468–1478.
   PubMed Web of Science ®Google Scholar
• Dalle F, Wächtler B, L'Ollivier C, Holland G, Bannert N, Wilson D, Labruère C, Bonnin A, Hube B. 2010. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol. 12:248–271.
   PubMed Web of Science ®Google Scholar
• Endo EH, Cortez DAG, Ueda-Nakamura T, Nakamura CV, Dias Filho BP. 2010. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans. Res Microbiol. 161:534–540.
   PubMed Web of Science ®Google Scholar
• Fadda ME, Podda GS, Pisano MB, Deplano M, Cosentino S. 2015. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three-year survey. J Prev Med Hyg. 49:69–74.
   Google Scholar
• Gow NA, Hube B. 2012. Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol. 15:406–412.
   PubMed Web of Science ®Google Scholar
• Gulati M, Nobile CJ. 2016. Candida albicans biofilms: development, regulation and molecular mechanisms. Microbes Infect. 16:1–30.
   Google Scholar
• Hemaiswarya S, Kruthiventi AK, Doble M. 2008. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 15:639–652.
   PubMed Web of Science ®Google Scholar
• Jacobsen ID, Wilson D, Wächtler B, Brunke S, Naglik JR, Hube B. 2012. Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther. 1:85–93.
   Google Scholar
• Khan MAS, Ahmad I. 2012. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J Antimicrob Chemother. 67:618–621.
   PubMed Web of Science ®Google Scholar
• Krumperman PH. 1983. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol. 46:165–170.
   PubMed Web of Science ®Google Scholar
• Ma C, Du F, Yan L, He G, He J, Wang C, Rao G, Jiang Y, Xu G. 2015. Potent activities of roemerine against Candida albicans and the underlying mechanisms. Molecules. 20:17913–17928.
   PubMed Web of Science ®Google Scholar
• Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. 2012. Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol. 120:1407–1414.
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. 2013. Candida albicans pathogenicity mechanisms. Virulence. 4:119–128.
   PubMed Web of Science ®Google Scholar
• Morschhäuser J. 2016. The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen. J Microbiol. 54:192–201.
   PubMed Web of Science ®Google Scholar
• Oliveira YLC, Silva LCN, Silva AG, Macedo AJ, Araújo JM, Correia MTS, Silva MV. 2012. Antimicrobial activity and phytochemical screening of Buchenavia tetraphylla (Aubl.) R. A. Howard (Combretaceae: Combretoideae). Sci World J. 2012:1–6.
   Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Zaoutis TE. 2015. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 62:e1–50.
   PubMedGoogle Scholar
• Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL, Noverr MC. 2014. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infect Immun. 82:532–543.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. 2010. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 36:1–53.
   PubMed Web of Science ®Google Scholar
• Sant’Anna da Silva AP, Nascimento da Silva LCN, Martins da Fonseca CS, de Araújo JM, Correia MT, Cavalcanti MS, Lima VL. 2016. Antimicrobial activity and phytochemical analysis of organic extracts from Cleome spinosa Jaqc. Front Microbiol. 7:963.
   PubMed Web of Science ®Google Scholar
• Santos Aliança AS, Anjos KF, Vasconcelos Reis TN, Higino TM, Brelaz-de-Castro MC, Bianco ÉM, Figueiredo RC. 2014. The in vitro biological activity of the Brazilian brown seaweed Dictyota mertensii against Leishmania amazonensis. Molecules. 19:14052–14065.
   PubMed Web of Science ®Google Scholar
• Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Giannini MM. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 62:10–24.
   PubMed Web of Science ®Google Scholar
• Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, Shirtliff ME. 2015. Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology (Reading, Engl.). 161:168–181.
   PubMed Web of Science ®Google Scholar
• Silva LCN, Sandes JM, Paiva MM, Araújo JM, Figueiredo RCBQD, da Silva MV, Correia MTDS. 2013. Anti-Staphylococcus aureus action of three Caatinga fruits evaluated by electron microscopy. Nat Prod Res. 27:1492–1496.
   PubMed Web of Science ®Google Scholar
• Silva LN, Trentin DDS, Zimmer KR, Treter J, Brandelli CLC, Frasson AP, Macedo AJ. 2014. Anti-infective effects of Brazilian Caatinga plants against pathogenic bacterial biofilm formation. Pharm Biol. 53:464–468.
   PubMed Web of Science ®Google Scholar
• Silva-Dias A, Miranda IM, Branco J, Monteiro-Soares M, Pina-Vaz C, Rodrigues AG. 2015. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. Front Microbiol. 6:1–8.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Panzer H. 2003. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother. 47:34–38.
   PubMed Web of Science ®Google Scholar
• Staniszewska M, Bondaryk M, Siennicka K, Kurzatkowski W. 2012. Ultrastructure of Candida albicans pleomorphic forms: phase-contrast microscopy, scanning and transmission electron microscopy. Pol J Microbiol. 61:129–135.
   PubMed Web of Science ®Google Scholar
• Teodoro GR, Brighenti FL, Delbem ACB, Delbem ÁCB, Khouri S, Gontijo AVL, Koga-Ito CY. 2015. Antifungal activity of extracts and isolated compounds from Buchenavia tomentosa on Candida albicans and non-albicans. Future Microbiol. 10:917–927.
   PubMed Web of Science ®Google Scholar
• Vuuren SV, Viljoen A. 2011. Plant-based antimicrobial studies methods and approaches to study the interaction between natural products. Planta Med. 77:1168–1182.
   PubMed Web of Science ®Google Scholar
• Wagner H, Ulrich-Merzenich G. 2009. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 16:97–110.
   PubMed Web of Science ®Google Scholar
• Weaver PL. 1991. Buchenavia tetraphylla (Vahl.) Eichler: Granadillo. New Orleans (LA): Department of Agriculture, Southern Forest Experiment Station.
   Google Scholar